D.N.J. Dismisses Antiperspirant Benzene Case with out Breaking a Sweat 


Greater than as soon as have we taken word of the present plaintiff lawyer infatuation with enlisting “impartial” (ha ha ha) laboratories that can handle to detect contaminants in any drug, beauty, or puddle of unicorn tears.  For instance, see our of the Zantac MDL magnum opus ruling the place the courtroom was lower than impressed by lab checks (a type of labs being Valisure) purporting to seek out carcinogens within the drugs.  As well as, final November we a case holding that Valisure’s purported findings of benzene in antiperspirant had been insufficient to prop up a product legal responsibility case below Louisiana regulation.  

Right now, we take a quick take a look at Temporary v. Idelle Labs, Ltd., 2023 WL 2860345  (D.N.J. April 10, 2023), which reached an identical end result below New Jersey regulation. A plaintiff claimed that he suffered from leukemia on account of benzene in his antiperspirant. The amended criticism alleged product defect below the New Jersey Merchandise Legal responsibility Act, with  claims for manufacturing defect, design defect, and failure to warn. The amended criticism prayed for each compensatory and punitive damages. That prayer is unlikely to be answered.  

The defendant moved to dismiss the Temporary case in its entirety.  (The defendant was not Procter & Gamble, however that wonderful firm will get talked about within the case as a result of it was the unique developer of the product. We point out such mentioning solely as a result of we had been distracted by the courtroom’s incorrect spelling of Procter as “Proctor.”  We have now seen that misspelling typically – from courts, plaintiff attorneys, and even protection attorneys.  However we by no means make that mistake, at the least not since a former P&G worker taught us to do not forget that P&G merchandise are bettER, not bettOR. With our model loyalty to Tide, Cascade, Daybreak, Braun, and plenty of different merchandise, that rubric rings true for us. Heck, P&G might rent us and pay the charges with Mach 3 blades.)

The plaintiff in Temporary tried to repel, evade, or delay the movement to dismiss by counting on extraneous supplies and by urging the courtroom to attend for discovery. Good strive. The Temporary courtroom refused to contemplate such extraneous supplies and wouldn’t enable lack of discovery to excuse insufficient pleading.  

How was the pleading within the Temporary amended criticism insufficient? The primary downside was the amended criticism’s full-blown reliance on a discovering by Valisure of benzene in three samples of the product from three particular tons, in addition to a subsequent recall of the product. However a Valisure-inspired recall was not sufficient to make out an precise defect. The Valisure report recognized “important variability” of benzene from batch to batch. Nowhere close to all of the examined merchandise had been contaminated, so it couldn’t be inferred that the plaintiff’s merchandise essentially had been. Nor can a voluntary recall represent an admission of defect — a degree for which we will definitely be citing Temporary in our briefs.  

Furthermore, the plaintiff insufficiently pled causation. The plaintiff stated that he “frequently” used the antiperspirant for “a few years” (this formulation will sound acquainted to veterans of the asbestos and talcum powder wars), however that rote recitation didn’t add as much as details displaying “excessive ranges” of benzene consumption.  In brief, the Valisure check outcomes weren’t a brief reduce to a sound lawsuit.  

Absent defect or causation, the Temporary case wanted to be slammed shut.  There have been, to make sure, defects within the Temporary case, however they resided within the causes of motion, not the product.  Every one of many causes of motion within the amended criticism suffered from a deadly flaw. 

First, the manufacturing defect failed as a result of the plaintiffs pointed to no defect or deviation within the manufacturing course of.  All that the plaintiff might plead was that benzene shouldn’t be within the product, so the presence of benzene should imply that one thing went incorrect. However the plaintiff recognized no “error or mishap” throughout manufacturing. Additional, the plaintiff’s concept was internally inconsistent. The courtroom held that “frequent sense dictates {that a} product can not deviate from one other equivalent product” when the plaintiff’s declare was that over the “a few years of standard use” the merchandise “suffered from the identical inherent flaw.”  That intelligent level, utilizing the plaintiffs’ publicity allegations to push the manufacturing defect declare proper out the courthouse door, resulted in dismissal of the manufacturing defect declare with prejudice. 

Second, the Temporary courtroom held that the design defect declare failed as a result of the plaintiff by no means made out an actual defect or various design. The plaintiff relied on the Valisure testing, not solely to point out the presence of benzene within the product at subject, but additionally to point out the shortage of benzene in different, related merchandise.  In keeping with the plaintiff, these different, benzene-free merchandise steered the provision of an alternate design. However, once more, the Valisure testing was incomplete and nonspecific to the plaintiff.  Perhaps the plaintiff might do a greater job of pleading the design defect explanation for motion (we’re skeptical), so the courtroom dismissed this depend with out prejudice. 

Third, the failure to warn declare ran headlong into New Jersey’s presumption that FDA mandated drug warnings are enough.  Antiperspirant spray merchandise are regulated as medication. The plaintiff didn’t plead any details hinting that the defendant ought to have recognized, based mostly on newly found info, of any hyperlink between the antiperspirant and leukemia, or that the defendant intentionally hid dangers. The plaintiff didn’t cobble collectively an allegation that any newly acquired info was withheld from the FDA. Thus, the courtroom additionally dismissed the failure to warn declare, although it did so with out prejudice.  

The plaintiff might want to put up or shut up.  One factor is bound (or, given the product at subject, Certain): the lab check outcomes will not be sufficient. We anticipate this lawsuit to have a quick lifespan.

Leave a Reply

Your email address will not be published. Required fields are marked *